levels News newsbot.ch

Wirtschaft »

Roche presents positive Phase III results for Tecentriq® (atezolizumab) in combination with platinum-based chemotherapy in people with previously untreated advanced bladder cancer

Roche presents positive Phase III results for Tecentriq® (atezolizumab) in combination with platinum-based chemotherapy in people with previously untreated advanced bladder cancer

2019-09-30 19:20:02


Wirtschaft »

Roche’s fixed-dose subcutaneous combination of Perjeta and Herceptin showed non-inferiority when compared to intravenous formulations for people with HER2-positive breast cancer

2019-09-13 13:20:50


Wirtschaft »

Roche’s Tecentriq as a first-line monotherapy helped certain people with advanced non-small cell lung cancer live longer compared with chemotherapy

2019-09-12 13:20:00


Wirtschaft »

Roche presents new OCREVUS (ocrelizumab) biomarker data that increase understanding of disease progression in multiple sclerosis at ECTRIMS

2019-09-10 05:40:12


Wirtschaft »

Roche to present pivotal data for satralizumab in neuromyelitis optica spectrum disorder and six-year OCREVUS data in multiple sclerosis at ECTRIMS

2019-09-04 06:40:12


Wirtschaft »

Roche launches VENTANA PD-L1 (SP142) Assay in CE markets as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq

2019-08-29 07:40:16


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

2019-07-31 09:24:45


Wirtschaft »

Roche mit sehr gutem Ergebnis im ersten Halbjahr 2019 – Ausblick angehoben

Roche mit sehr gutem Ergebnis im ersten Halbjahr 2019 – Ausblick angehoben

2019-07-25 05:40:00


Wirtschaft »

FDA grants Roche’s Polivy accelerated approval for people with previously treated aggressive lymphoma

2019-06-11 14:40:06


Wirtschaft »

Roche and Spark Therapeutics, Inc. receive Request for Additional Information from FTC under Hart-Scott-Rodino Act and announce extension of tender offer for shares of Spark Therapeutics, Inc.

2019-06-10 12:40:00


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

2019-05-14 05:20:02


Wirtschaft »

New Roche data at the 2019 AAN Annual Meeting showcase breadth and promise of neuroscience portfolio

2019-04-29 17:20:00


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

2019-04-03 15:40:15


Wirtschaft »

Roche’s VENTANA PD-L1 (SP142) Assay approved as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq in combination with Abraxane

2019-03-11 08:40:04


Wirtschaft »

Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in cash

2019-03-07 19:20:03


Wirtschaft »

Roche und Spark Therapeutics schliessen verbindliche Übernahmevereinbarung

2019-02-25 19:20:33


Wirtschaft »

Roche enters into definitive merger agreement to acquire Spark Therapeutics

2019-02-25 09:20:18


Wirtschaft »

PRIME designation granted by European Medicines Agency for Roche’s risdiplam for treatment of spinal muscular atrophy (SMA)

PRIME designation granted by European Medicines Agency for Roche’s risdiplam for treatment of spinal muscular atrophy (SMA)

2018-12-17 07:40:04


Wirtschaft »

Roche’s Hemlibra provided sustained bleed control in the largest pivotal study to date of children with haemophilia A with factor VIII inhibitors

Roche’s Hemlibra provided sustained bleed control in the largest pivotal study to date of children with haemophilia A with factor VIII inhibitors

2018-12-03 19:20:13


Wirtschaft »

Generali Schweiz und Swiss Post Solutions (SPS) beschliessen Kooperation

2018-03-21 19:40:02



Suchresultate als RSS-Feed